COVID-19 vaccine technology benefits devils
Since the emergence of the facial fungal disease during the mid-1990s that has decimated Tasmanian devil populations in the wild, scientists have been working on developing a vaccine that can protect the species and slow the spread of the fatal cancer. Although there was limited success with an earlier immunotherapy trial, that saw some captive-bred […]
Continue Reading